Navigation Links
Executive Changes at Ampio
Date:1/9/2012

GREENWOOD VILLAGE, Colo., Jan. 9, 2012 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NASDAQ: AMPE) ("Ampio" or the "Company"), a company that discovers and develops new uses for previously approved drugs and new molecular entities, announced that CEO Don Wingerter would be granted a compassionate leave from all his duties at the company in order to attend to serious illnesses afflicting his closest family members.  The term of leave is currently unknowable and should be considered indefinite at this time.  Taking over the position of CEO will be Michael Macaluso, current Chairman of the Ampio Board of Directors and lead investor in DMI BioSciences, predecessor company to Ampio. 

Philip Coelho, Chairman of the Nominating and Governance committee of the Board, commented  "The entire Board would like to express our appreciation of all the excellent work performed by Don Wingerter over the last two years especially because we were all aware of the deteriorating health of his parents and saw the great strain that it was causing him.  We fully respect his decision to devote his full efforts to his family at this most urgent time and wish him all the best." 

"Fortunately for Ampio shareholders, Mr. Macaluso has agreed to assume the duties of CEO immediately and, in the unanimous opinion of the Board, could not be more qualified by intelligence, determination and knowledge of the issues before us.  Mr. Macaluso previously served as CEO managing the turn-around at Isolagen from August 2001 until September 2004. Isolagen's commercial efforts had been terminated by FDA intervention and the company was on the verge of bankruptcy.  Mr. Macaluso led a group of investors that provided Isolagen credit during the due diligence period and a significant investment thereafter.  As CEO, Mr. Macaluso quickly refocused the business goals of Isola
'/>"/>

SOURCE Ampio Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. US HIFU Names New Chief Executive Officer
2. ECRI Institute Puts 10 Technology Issues on its 2012 Watch List for Hospital Executives
3. Novocure Adds Three Senior Oncology Executives to its Global Management Team
4. Veteran Healthcare and Pharmacy Executive Craig Stephens Joins Diplomat Specialty Pharmacy as Group Vice President of Business Development and Trade Relations
5. Essentialis Promotes Aaron Berg to Chief Executive Officer
6. Prasco Announces New, Expanded Roles for Key Executives
7. Tengion Appoints John L. Miclot President and Chief Executive Officer
8. Astellas Adds Two Key Senior Executives at Agensys, Inc.
9. Leading Executives Once Again Meet at GDS International’s Next Generation Pharmaceutical Manufacturing Europe Summit to Discuss Key Objectives For The Industry
10. Alacrita Launches Charity Auction of Executive One-to One Lunches with Senior Figures from the Pharmaceutical and Venture Capital Industries
11. Dune Medicals Chief Executive to Present at Upcoming Piper Jaffray Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... , July 24, 2014  Perrigo Company (NYSE: ... has received an AB therapeutic equivalent rating from the ... approved New Drug Application (NDA) for testosterone gel 1.0%. ... to [AbbVie,s] AndroGel 1% and can be substituted with ... clinical effect and safety profile as AndroGel 1% when ...
(Date:7/24/2014)... 24, 2014 Talyst, a market leader in ... Association of State Veterans Homes (NASVH) Summer Conference in ... of the NASVH is to ensure that each and ... term health care and respect which they have earned ... the InSite® Remote Dispensing System, Talyst can help State ...
(Date:7/24/2014)... Calif. , July 24, 2014  Lazarus ... development of novel interventional devices to facilitate removal ... States Patent and Trademark Office has issued a ... technology behind the company,s Lazarus Cover TM ... The Lazarus ReCover is a single-component stent-retriever (stentriever) ...
Breaking Medicine Technology:Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 2Perrigo Confirms AB Therapeutic Equivalent Rating From The FDA For Its Testosterone Gel 1.0% 3Talyst Exhibits at the National Association of State Veterans Homes Summer Conference 2Lazarus Effect Receives Notice of Allowance for New US Patent Covering Core Protection Technology 2
... Results Expected in November 2008, BOTHELL, Wash., Oct. ... today the completion of patient enrollment and dosing,for the ... safety and,efficacy of its formulation of 12-hour extended-release (ER) ... report top-line,results from this pivotal trial in November 2008. ...
... world,s most influential medical journal, the New England Journal,of ... company,s study,of the Diamyd(R) diabetes vaccine for type 1 ... article is now available on the journal,s web site,( ... 30. It presents the,results of the concluded Phase II ...
Cached Medicine Technology:SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 2SCOLR Pharma Announces Completion of Patient Enrollment and Dosing for Pivotal Clinical Trial Evaluating Extended Release Ibuprofen 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 2Diamyd(R) Study Published in Prestigious New England Journal of Medicine 3Diamyd(R) Study Published in Prestigious New England Journal of Medicine 4
(Date:7/25/2014)... July 25, 2014 In an election year ... no surprise that Americans may not be sleeping well, and ... to a new poll conducted by US-Mattress . The ... across the country, “Which Political Party Do You Side With,” ... those registered as Independents tout a higher rate of good ...
(Date:7/25/2014)... NY (PRWEB) July 25, 2014 Ticket ... the Guinness International Champions Cup Match between Manchester City ... New York, one of the most iconic locations is Yankee ... Yankee Stadium, but it is quickly becoming a location that ... facility is home to the New York Yankees from Major ...
(Date:7/25/2014)... Oncology (ESMO), the leading pan-European association representing medical ... EU General Data Protection Regulation [1] could make ... to both doctors and cancer patients. , The ... and specific patient consent, meaning that researchers would ... is planned in order to consult their data ...
(Date:7/25/2014)... July 25, 2014 Yisrayl Hawkins, Pastor and ... article on his blog explaining why so many prayers are ... most. , In the article, Yisrayl gives many examples ... shares the results. For example, in one case, in the ... church grounds to pray for rain; ironically, they received a ...
(Date:7/25/2014)... 2014 iTanSmart is a patented iOS ... app provides a tailored approach to eliminating the guesswork ... and skin damage. In his review, Eaton had positive ... of iTanSmart. , Eaton begins his commentary ... ‘better organized’ and ‘great alternative’ to its related Android ...
Breaking Medicine News(10 mins):Health News:New Study Shows the Growing Number of Independent Voters Have a Greater Propensity for Sleeping Well vs. Democrats or Republicans 2Health News:New Study Shows the Growing Number of Independent Voters Have a Greater Propensity for Sleeping Well vs. Democrats or Republicans 3Health News:Manchester City vs. Liverpool FC Tickets Yankee Stadium: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match in NYC on July 30th 2Health News:Manchester City vs. Liverpool FC Tickets Yankee Stadium: Ticket Down Cuts Ticket Prices for Guinness International Champions Cup Match in NYC on July 30th 3Health News:Is Europe putting cancer research at risk? 2Health News:Yisrayl Hawkins Says Prayers for Rain Result in Violent Hail Because Prayers Are Not Being Heard in New Post 2Health News:Yisrayl Hawkins Says Prayers for Rain Result in Violent Hail Because Prayers Are Not Being Heard in New Post 3Health News:iTanSmart® Suntan App by UV Technologies, LLC Gets a ‘Big Thumbs Up’ from New York Times App Smart Columnist, Kit Eaton 2Health News:iTanSmart® Suntan App by UV Technologies, LLC Gets a ‘Big Thumbs Up’ from New York Times App Smart Columnist, Kit Eaton 3
... don,t protect against UVA rays, which can cause skin cancer ... of the most popular protections people use as the summer ... harmful ultraviolet rays. , Sunburns are not only painful, they ... cancer in the United States. , But, new research has ...
... WASHINGTON, July 12 Speaker Nancy Pelosi,issued the following statement ... "In his 70 years of medical practice, Dr. DeBakey had ... the globe by literally fixing, broken hearts. We honored ... Medal earlier this year., "Dr. DeBakey was one of ...
... , , SATURDAY, July 12 (HealthDay News) -- Summer is the ... is also the time for them to be most aware ... thunder roars, go indoors," Mary Ann Cooper, director of the ... Chicago, said in a prepared statement. "Decisions about lightning safety ...
... Emageon Inc.,(Nasdaq: EMAG ), a leader ... networks and imaging facilities,announced today that the Strategic ... Jefferies and Company as Lead Advisor and SunTrust,Robinson ... it evaluates all,strategic options available to the company., ...
... A,democratic process involving several SEIU local unions that began ... the best way to unite,long-term care workers in California ... their families and the clients they serve., "Today,s ... democratic,discussion to make sure that California long-term care workers ...
... million in cuts, WASHINGTON, July 11 Hundreds ... pay more out of pocket,for health care, while thousands ... approved this week by the U.S. Congress., The ... the,Medicare Advantage program over a five-year period, including cutting ...
Cached Medicine News:Health News:Are You Getting Burned by Your Sunscreen? 2Health News:Are You Getting Burned by Your Sunscreen? 3Health News:Summer Is Peak Time for Lightning Strikes 2Health News:Florida Seniors' Medicare Advantage Benefits at Risk 2
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... reference laboratory and a worldwide leader in ... an extensive test menu of highly complex ... anatomic pathology. Owned by the University of ... half of the nation's university teaching hospitals ...
Medicine Products: